Atherogenesis and ischemic heart disease

American Journal of Cardiology

Volumn 80, Issue 8 B, 1997, Pages

  Selwyn, Andrew P ^a   Kinlay, Scott ^a   Ganz, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030833953     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00813-8     Document Type: Conference Paper

References (48)

1. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 114:1984;79-93.
2. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 125:1986;191-207.
3. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 140:1992;907-914.
4. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system recent advances . FASEB J. 10:1996;283-292.
5. Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 95:1997;5-7.
6. Grimbrone MA Jr, Resnick N, Nagel T, Knachigian LM, Collins T, Topper JN. Hemodynamics, endothelial gene expression, and atherogenesis. Ann NY Acad Sci. 811:1997;1-10, discussion 10-1 ISSN: 0077-8923.
7. Gimbrone MA Jr, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci. 748:1995;122-131; discussion 131-2 ISSN:0077-8923.
8. Gimbrone MA Jr. Endothelial dysfunction and atherosclerosis. J Card Surg. 4:1989;180-183.
9. Davies PF, Remuzzi A, Gordon EJ, Dewey CF Jr, Gimbrone MA Jr. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci USA. 83:1986;2114-2117.
10. Cox DA, Cohen ML. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation clinical and pharmacological implications in atherosclerosis . Pharmacological Reviews. 48:1996;3-16.
11. McLenachan JM, Vita J, Fish DR, Treasure CB, Cox DA, Ganz P, Selwyn AP. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation. 82:1990;1169-1173.
12. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:1991;788-791.
13. Gimbrone MA Jr. Atherogenesis current concepts . Monogr Pathol. 37:1995;1-11.
14. Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 79:(suppl):1997;17-23.
15. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 331:1994;468-469.
16. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 13:1993;197-204.
17. Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann NY Acad Sci. 598:1990;77-85.
18. Libby P, Geng YJ, Sukhova GK, Simon DI, Lee RT. Molecular determinants of atherosclerotic plaque vulnerability. Ann N Y Acad Sci. 811:1997;134-142; discussion 142\N5.
19. Khachigian LM, Resnick N, Gimbrone MA Jr, Collins T. Nuclear factor-kB interacts functionally with the platelet-derived growth factor B-chain shear-stress-response-element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest. 96:1995;1169-1175.
20. Collis T. Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest. 68:1993;499-508.
21. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules NF-kB and cytokine-inducible enhancers . FASEB J. 9:1995;899-909.
22. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis current knowledge and unanswered questions . Lab Invest. 64:1991;5-15.
23. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
24. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci. 748:1995;501-501.
25. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med. 116:1992;1292-1300.
26. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:1997;205-212.
27. Harrison DG, Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis implications for impaired vasomotion . Am J Cardiol. 75:(suppl):1995;75B-81B.
28. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 98:1996;2572-2579.
29. Harrison DG. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol. 89:(suppl):1994;87-102.
30. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 337:1997;408-416.
31. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages implications for CD40-CD40 ligand signaling in atherosclerosis . Proc Natl Acad Sci USA. 94:1997;1931-1936.
32. Libby P, Geng YJ, Aikawa M, Shoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 7:1996;330-335.
33. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:1997;205-212.
34. Gimbrone MA Jr, Resnick N, Nagel T, Khachigian LM, Collins T, Topper JN. Hemodynamics, endothelial gene expression, and atherogenesis. Ann N Y Acad Sci. 811:1997;1-10, discussion 10-1.
35. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol. 75:(suppl):1995;24C-33C.
36. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
37. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 75:(suppl):1995;71B-74B.
38. Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP, Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650.
39. Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 85:1992;1390-1397.
40. Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 83:1989;1946-1952.
41. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 84:1991;1273-1278.
42. Vita JA, Treasure CB, Ganz P, Cox DA, Fish RD, Selwyn AP. Control of shear stress in the epicardial coronary arteries of humans impairment by atherosclerosis . J Am Coll Cardiol. 14:1989;1193-1199.
43. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ Jr, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 325:1991;1551-1556.
44. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 95:1997;76-82.
45. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
46. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
47. Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 95:1997;324-328.
48. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr, Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 93:1996;1334-1338.